Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prone Position | 3 | 2021 | 57 | 1.100 |
Why?
|
| Patient Positioning | 3 | 2021 | 65 | 1.080 |
Why?
|
| Otolaryngology | 3 | 2022 | 55 | 0.930 |
Why?
|
| Silk | 1 | 2023 | 2 | 0.890 |
Why?
|
| Vocal Cord Paralysis | 1 | 2023 | 27 | 0.880 |
Why?
|
| Laryngostenosis | 2 | 2021 | 18 | 0.870 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 51 | 0.860 |
Why?
|
| Device Approval | 1 | 2022 | 13 | 0.800 |
Why?
|
| Glossitis | 1 | 2021 | 3 | 0.770 |
Why?
|
| Vocal Cords | 5 | 2024 | 28 | 0.720 |
Why?
|
| Lasers, Solid-State | 1 | 2020 | 8 | 0.720 |
Why?
|
| Rhinoscleroma | 1 | 2020 | 2 | 0.700 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 147 | 0.690 |
Why?
|
| Cysts | 1 | 2020 | 106 | 0.660 |
Why?
|
| Nasal Polyps | 1 | 2020 | 62 | 0.650 |
Why?
|
| Voice Quality | 2 | 2024 | 7 | 0.430 |
Why?
|
| Tongue | 3 | 2021 | 57 | 0.420 |
Why?
|
| Platelet-Rich Plasma | 2 | 2024 | 11 | 0.420 |
Why?
|
| Dysphonia | 3 | 2021 | 5 | 0.410 |
Why?
|
| Laryngoscopy | 3 | 2021 | 47 | 0.400 |
Why?
|
| Larynx | 2 | 2021 | 37 | 0.360 |
Why?
|
| Injections | 2 | 2024 | 116 | 0.270 |
Why?
|
| Cicatrix | 2 | 2024 | 68 | 0.270 |
Why?
|
| Treatment Outcome | 7 | 2024 | 8292 | 0.260 |
Why?
|
| Middle Aged | 11 | 2024 | 26173 | 0.240 |
Why?
|
| Laryngeal Diseases | 2 | 2024 | 21 | 0.240 |
Why?
|
| Humans | 20 | 2024 | 90014 | 0.230 |
Why?
|
| Retrospective Studies | 7 | 2022 | 9237 | 0.220 |
Why?
|
| Medical Device Recalls | 1 | 2022 | 1 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2024 | 4329 | 0.200 |
Why?
|
| Pharynx | 1 | 2022 | 44 | 0.200 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2022 | 38 | 0.200 |
Why?
|
| Voice Training | 1 | 2021 | 2 | 0.200 |
Why?
|
| High-Frequency Jet Ventilation | 2 | 2012 | 3 | 0.190 |
Why?
|
| Edema | 1 | 2021 | 70 | 0.190 |
Why?
|
| Male | 11 | 2024 | 42705 | 0.190 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 135 | 0.190 |
Why?
|
| Lighting | 1 | 2021 | 33 | 0.190 |
Why?
|
| Facial Dermatoses | 1 | 2021 | 13 | 0.180 |
Why?
|
| Dyspnea | 1 | 2021 | 76 | 0.180 |
Why?
|
| Facial Injuries | 1 | 2021 | 20 | 0.180 |
Why?
|
| Chondroma | 1 | 2020 | 7 | 0.180 |
Why?
|
| Ultrasonic Surgical Procedures | 1 | 2020 | 6 | 0.180 |
Why?
|
| Suction | 1 | 2020 | 37 | 0.180 |
Why?
|
| Pulmonary Veins | 2 | 2012 | 93 | 0.180 |
Why?
|
| Laryngitis | 1 | 2020 | 2 | 0.180 |
Why?
|
| Pressure Ulcer | 1 | 2021 | 43 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2021 | 66 | 0.180 |
Why?
|
| Aged | 6 | 2024 | 19272 | 0.170 |
Why?
|
| Laryngoscopes | 1 | 2020 | 9 | 0.170 |
Why?
|
| Wakefulness | 1 | 2020 | 135 | 0.170 |
Why?
|
| Beauty | 1 | 2019 | 8 | 0.170 |
Why?
|
| Phosphates | 1 | 2020 | 161 | 0.170 |
Why?
|
| Men | 1 | 2019 | 10 | 0.170 |
Why?
|
| Masculinity | 1 | 2019 | 16 | 0.170 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 162 | 0.170 |
Why?
|
| Adult | 7 | 2024 | 26836 | 0.160 |
Why?
|
| Potassium | 1 | 2020 | 258 | 0.160 |
Why?
|
| Cosmetic Techniques | 1 | 2019 | 29 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 281 | 0.160 |
Why?
|
| Catheter Ablation | 2 | 2012 | 254 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1731 | 0.160 |
Why?
|
| Social Perception | 1 | 2019 | 94 | 0.160 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 358 | 0.160 |
Why?
|
| Equipment Design | 1 | 2020 | 422 | 0.150 |
Why?
|
| Personality | 1 | 2019 | 136 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 257 | 0.140 |
Why?
|
| Professional Practice | 1 | 2017 | 46 | 0.140 |
Why?
|
| Accreditation | 1 | 2017 | 61 | 0.140 |
Why?
|
| Atrial Fibrillation | 2 | 2012 | 357 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 3684 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 608 | 0.130 |
Why?
|
| Workload | 1 | 2017 | 129 | 0.130 |
Why?
|
| Female | 8 | 2024 | 46617 | 0.130 |
Why?
|
| Time Factors | 1 | 2023 | 5361 | 0.120 |
Why?
|
| United States | 3 | 2022 | 7114 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6787 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 403 | 0.110 |
Why?
|
| Anesthesia, General | 1 | 2012 | 116 | 0.090 |
Why?
|
| Risk Factors | 1 | 2021 | 5562 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 157 | 0.080 |
Why?
|
| Anesthesia | 1 | 2011 | 169 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2017 | 1063 | 0.070 |
Why?
|
| Stroboscopy | 1 | 2024 | 2 | 0.060 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 196 | 0.050 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2021 | 10 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 140 | 0.050 |
Why?
|
| Cricoid Cartilage | 1 | 2020 | 4 | 0.050 |
Why?
|
| Voice Disorders | 1 | 2020 | 7 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2021 | 281 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 222 | 0.040 |
Why?
|
| Hoarseness | 1 | 2020 | 11 | 0.040 |
Why?
|
| Atrophy | 1 | 2021 | 124 | 0.040 |
Why?
|
| Ulcer | 1 | 2020 | 37 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2658 | 0.040 |
Why?
|
| Photography | 1 | 2019 | 37 | 0.040 |
Why?
|
| Observer Variation | 1 | 2021 | 614 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 387 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 335 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 462 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 778 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2770 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1913 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2012 | 50 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2012 | 91 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 201 | 0.020 |
Why?
|
| Respiratory Mechanics | 1 | 2011 | 102 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 776 | 0.020 |
Why?
|
| Oxygen | 1 | 2012 | 746 | 0.020 |
Why?
|